CLINICAL_TRIALS
research
· 2025-04-02
Clinical Trial Update: 18F-Floretyrosine Expanded Access Program
Summary
Expanded access program for the PET imaging tracer 18F-Floretyrosine is currently available for glioma patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited | Conditions: Glioma (Any Grade) in the Brain | Status: AVAILABLE